Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis
- 1 March 2013
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 180 (1), 97-103
- https://doi.org/10.1016/j.jss.2012.10.053
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS TrialJournal of Clinical Oncology, 2009
- KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver MetastasesAnnals of Surgical Oncology, 2009
- A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal CancerJournal of Clinical Oncology, 2009
- Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Appendiceal neoplasms and pseudomyxoma peritonei: A population based studyEuropean Journal of Surgical Oncology, 2008
- KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximabAnnals of Oncology, 2007
- Pseudomyxoma Peritonei of Appendiceal Origin: A Clinicopathologic Analysis of 101 Patients Uniformly Treated at a Single Institution, With Literature ReviewThe American Journal of Surgical Pathology, 2006
- Appendiceal Neoplasms With Peritoneal Dissemination: Outcomes After Cytoreductive Surgery and Intraperitoneal Hyperthermic ChemotherapyAnnals of Surgical Oncology, 2006
- Molecular Genetic Evidence Supporting the Clonality and Appendiceal Origin of Pseudomyxoma Peritonei in WomenThe American Journal of Pathology, 1999
- A Clinicopathologic Analysis of 109 Cases with Emphasis on Distinguishing Pathologic Features, Site of Origin, Prognosis, and Relationship to “Pseudomyxoma Peritonei”The American Journal of Surgical Pathology, 1995